Objective:To predict the effects of a new antiretroviral agent on the costs of care in a US HIV care setting. Methods: Recent data on costs of patient care by CD4 count from 2 US cohorts (the HIV ...

HIV viruses infecting T-lymphocytes, computer illustration. The surface of the T-cell has a lumpy appearance with large irregular surface protrusions. Smaller spherical structures on the cell surface ...

Heterosexuals with HIV have lower CD4 counts at diagnosis than their gay and bisexual male peers, according to an analysis of more than 300,000 people living with HIV globally. "It was quite a ...

Feb. 8, 2006 (Denver) — With increasing concern over treatment-related morbidities in patients on long-term antiretroviral therapy (ART), different strategies to reduce morbidities while maintaining ...

HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative ...

For adults infected with HIV in Thailand a monitoring strategy based on CD4 count (a type of white blood cell) is non-inferior to the recommended monitoring strategy measuring the amount of HIV virus ...

A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...

Please provide your email address to receive an email when new articles are posted on . HIV-infected individuals with a low CD4 count experienced a longer duration of influenza virus shedding, ...

Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...

Please provide your email address to receive an email when new articles are posted on . Data from an NIH-funded study in AIDS suggest the majority of children with HIV eventually recover their CD4 ...

Background. In recent years, treatment options for human immunodeficiency virus type 1 (HIV-1) infection have changed from nonboosted protease inhibitors (Pis) to nonnucleoside reverse-transcriptase ...